+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Contrast Media Market, by Product Type, by Application, by Modality, by Region, Industry Analysis and Forecast, 2019 - 2025

  • ID: 5006134
  • Report
  • February 2020
  • Region: Global
  • 233 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Bayer AG
  • Bracco S.p.A.
  • Lantheus Holdings, Inc.
  • The Guerbet Group
  • MORE
The Global Contrast Media Market size is expected to reach $6.3 billion by 2025, rising at a market growth of 3.52% CAGR during the forecast period. The contrast media market is still in the growing phase but will evolve significantly in the years to come. The factors attributing to market growth include an increase in image-guided surgical procedures, improvements in medical technology, an increase in diagnostic imaging, and an increase in cancer and cardiac disorder rates.

Various factors such as the rise in acceptability for contrast agents and the increasing number of diagnostic centers that have expanded diagnostic imaging services contribute to the growth of the market. Several advanced methods, such as the technologies used in MRI imaging is a gas microbubble, are likely to boost the market growth. Factors including growing investments in the contrast media market and the changes in the radiopharmaceuticals and healthcare sector are fueling the market growth.

In several radiology procedures, the iodinated and gadolinium-based contrast media are used frequently. These agents are often crucial to providing an accurate diagnosis and are almost always effective and safe when properly administered. Reactions to contrast media, nevertheless, do occur and may be life-threatening. Hence, understanding how reactions to contrast agents manifest and how to handle them promptly are important for the faculty and personnel.

Gadolinium contrast media (sometimes referred to as an MRI contrast media, chemicals, or 'dyes') are chemical compounds used in MRI scans. When the gadolinium contrast medium is inserted into the body, it strengthens and boosts the accuracy of the MRI pictures (or images). It helps the radiologist (a specialist doctor qualified to examine the images and send the doctor or physician a written report) to report more precisely on how the body works and whether there is any illness or abnormality present.

Based on Product Type, the market is segmented into Iodinated, Barium-based, Gadolinium-based and Microbubble. Based on Application, the market is segmented into Neurological disorders, Cancer, Cardiovascular disorders, Gastrointestinal disorders, Nephrological disorders, Musculoskeletal disorders and Other Applications. Based on Modality, the market is segmented into X-ray/CT, MRI and Ultrasound. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The major strategies followed by the market participants are Product Launches and Partnerships. Based on the Analysis presented in the Cardinal matrix, Bayer AG and Daiichi Sankyo Company, Limited are some of the forerunners in the Contrast Media Market. Companies such as General Electric (GE) Co., The Guerbet Group, Bracco S.p.A., Trivitron Healthcare Pvt. Ltd., and Lantheus Holdings, Inc. are some of the key innovators in Contrast Media Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bayer AG, General Electric (GE) Co. (GE Healthcare), The Guerbet Group, Lantheus Holdings, Inc., Bracco S.p.A., Trivitron Healthcare Pvt. Ltd., Nano Therapeutics Pvt. Ltd., Magnus Health, LLC (Veracross LLC), Imax Diagnostic Imaging Limited, and Daiichi Sankyo Company, Limited.

Recent strategies deployed in Contrast Media Market

Partnerships, Collaborations, and Agreements:

Nov-2019: Guerbet came into partnership with InterSystems, a leader in information technology platform particular for Healthcare. The partnership was aimed at optimizing the combination of Contrast & Care contrast media injection management solution into the IT systems of hospitals and medical imaging centers.

Sep-2019: Guerbet partnered with IBM Watson. The partnership was aimed at working on artificial intelligence software for diagnosing liver cancer.

Jun-2019: Daiichi Sankyo signed an agreement with GE Healthcare. Under this agreement, Daiichi transferred the exclusive development and marketing rights in Japan for four diagnostics imaging agents to GE Healthcare. It also transferred the marketing authorization rights in Japan to GE Healthcare Pharma Limited.

Jan-2018: Trivitron signed a joint venture agreement with IFHA. This joint agreement was focused on the African Continent. The joint venture company provides turn-key solutions, medical services, engineering support, etc. Both the companies have equal ownership in this JV.

Acquisition and Mergers:

Oct-2019: Lantheus Holdings signed an agreement to acquire Progenics Pharmaceuticals. This acquisition brought the therapeutics and imaging agents of the latter company to Lantheus. Its portfolio is expected to complement the diagnostic capabilities of Lantheus.

Oct-2017: Bracco Imaging acquired SurgVision, a real-time fluorescence image-guided surgery start-up. The acquisition helped the company in becoming the most advanced company. The portfolio of SurgVision expanded the imaging solutions of Bracco.

Product Launches and Product Expansions:

Sep-2019: Bayer launched the Medrad Stellant Flex CT injection system. This system provides individualized patient protocols and personalized imaging for capital equipment with the company's TechCare program.

Feb-2019: Bayer introduced the MEDRAD Centargo CT injection system. This is the latest addition to its range of imaging products.

Jul-2018: GE released Omnipaque (iohexol) Oral Solution in the US. This is a new ready-to-drink contrast medium, which can be used to help the physicians in diagnosing medical conditions through improving the diagnostic visualization of the abdominal gastrointestinal tract.

Jul-2018: GE unveiled Clariscan (gadoteric acid), a new macrocyclic MRI contrast agent in Korea. This launch expanded the company's foothold in Korea. This is a gadolinium-based contrast agent, which has been indicated for use with MRI in the brain, spine, and associated tissue in adults. Earlier, in Mar-2017, GE launched this contrast agent in Europe.

Mar-2018: Guerbet introduced OptiVantage multi-use contrast media injector in Europe. This injector was designed for injecting the contrast agents used in computed tomography (CT) scan medical examinations.

Scope of the Study

Market Segmentation:

By Product Type
  • Iodinated
  • Barium-based
  • Gadolinium-based
  • Microbubble
By Application
  • Neurological disorders
  • Cancer
  • Cardiovascular disorders
  • Gastrointestinal disorders
  • Nephrological disorders
  • Musculoskeletal disorders
  • Other Applications
By Modality
  • X-ray/CT
  • MRI
  • Ultrasound
By Geography

North America
  • US
  • Canada
  • Mexico
  • Rest of North America
Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA
Companies Profiled
  • Bayer AG
  • General Electric (GE) Co. (GE Healthcare)
  • The Guerbet Group
  • Lantheus Holdings, Inc.
  • Bracco S.p.A.
  • Trivitron Healthcare Pvt. Ltd.
  • Nano Therapeutics Pvt. Ltd.
  • Magnus Health, LLC (Veracross LLC)
  • Imax Diagnostic Imaging Limited
  • Daiichi Sankyo Company, Limited
Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Bayer AG
  • Bracco S.p.A.
  • Lantheus Holdings, Inc.
  • The Guerbet Group
  • MORE
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Contrast Media Market, by Product Type
1.4.2 Global Contrast Media Market, by Application
1.4.3 Global Contrast Media Market, by Modality
1.4.4 Global Contrast Media Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : Sep, 2019-Mar, 2015) Leading Players

Chapter 4. Global Contrast Media Market by Product Type
4.1 Global Iodinated Market by Region
4.2 Global Barium-based Market by Region
4.3 Global Gadolinium-based Market by Region
4.4 Global Microbubble Market by Region

Chapter 5. Global Contrast Media Market by Application
5.1 Global Neurological disorders Market by Region
5.2 Global Cancer Market by Region
5.3 Global Cardiovascular disorders Market by Region
5.4 Global Gastrointestinal disorders Market by Region
5.5 Global Nephrological disorders Market by Region
5.6 Global Musculoskeletal disorders Market by Region
5.7 Global Other Applications Market by Region

Chapter 6. Global Contrast Media Market by Modality
6.1 Global X-ray/CT Market by Region
6.2 Global MRI Market by Region
6.3 Global Ultrasound Market by Region

Chapter 7. Global Contrast Media Market by Region
7.1 North America Contrast Media Market
7.1.1 North America Contrast Media Market by Product Type
7.1.1.1 North America Iodinated Market by Country
7.1.1.2 North America Barium-based Market by Country
7.1.1.3 North America Gadolinium-based Market by Country
7.1.1.4 North America Microbubble Market by Country
7.1.2 North America Contrast Media Market by Application
7.1.2.1 North America Neurological disorders Market by Country
7.1.2.2 North America Cancer Market by Country
7.1.2.3 North America Cardiovascular disorders Market by Country
7.1.2.4 North America Gastrointestinal disorders Market by Country
7.1.2.5 North America Nephrological disorders Market by Country
7.1.2.6 North America Musculoskeletal disorders Market by Country
7.1.2.7 North America Other Applications Market by Country
7.1.3 North America Contrast Media Market by Modality
7.1.3.1 North America X-ray/CT Market by Country
7.1.3.2 North America MRI Market by Country
7.1.3.3 North America Ultrasound Market by Country
7.1.4 North America Contrast Media Market by Country
7.1.4.1 USA Contrast Media Market
7.1.4.1.1 USA Contrast Media Market by Product Type
7.1.4.1.2 USA Contrast Media Market by Application
7.1.4.1.3 USA Contrast Media Market by Modality
7.1.4.2 Canada Contrast Media Market
7.1.4.2.1 Canada Contrast Media Market by Product Type
7.1.4.2.2 Canada Contrast Media Market by Application
7.1.4.2.3 Canada Contrast Media Market by Modality
7.1.4.3 Mexico Contrast Media Market
7.1.4.3.1 Mexico Contrast Media Market by Product Type
7.1.4.3.2 Mexico Contrast Media Market by Application
7.1.4.3.3 Mexico Contrast Media Market by Modality
7.1.4.4 Rest of North America Contrast Media Market
7.1.4.4.1 Rest of North America Contrast Media Market by Product Type
7.1.4.4.2 Rest of North America Contrast Media Market by Application
7.1.4.4.3 Rest of North America Contrast Media Market by Modality
7.2 Europe Contrast Media Market
7.2.1 Europe Contrast Media Market by Product Type
7.2.1.1 Europe Iodinated Market by Country
7.2.1.2 Europe Barium-based Market by Country
7.2.1.3 Europe Gadolinium-based Market by Country
7.2.1.4 Europe Microbubble Market by Country
7.2.2 Europe Contrast Media Market by Application
7.2.2.1 Europe Neurological disorders Market by Country
7.2.2.2 Europe Cancer Market by Country
7.2.2.3 Europe Cardiovascular disorders Market by Country
7.2.2.4 Europe Gastrointestinal disorders Market by Country
7.2.2.5 Europe Nephrological disorders Market by Country
7.2.2.6 Europe Musculoskeletal disorders Market by Country
7.2.2.7 Europe Other Applications Market by Country
7.2.3 Europe Contrast Media Market by Modality
7.2.3.1 Europe X-ray/CT Market by Country
7.2.3.2 Europe MRI Market by Country
7.2.3.3 Europe Ultrasound Market by Country
7.2.4 Europe Contrast Media Market by Country
7.2.4.1 Germany Contrast Media Market
7.2.4.1.1 Germany Contrast Media Market by Product Type
7.2.4.1.2 Germany Contrast Media Market by Application
7.2.4.1.3 Germany Contrast Media Market by Modality
7.2.4.2 UK Contrast Media Market
7.2.4.2.1 UK Contrast Media Market by Product Type
7.2.4.2.2 UK Contrast Media Market by Application
7.2.4.2.3 UK Contrast Media Market by Modality
7.2.4.3 France Contrast Media Market
7.2.4.3.1 France Contrast Media Market by Product Type
7.2.4.3.2 France Contrast Media Market by Application
7.2.4.3.3 France Contrast Media Market by Modality
7.2.4.4 Russia Contrast Media Market
7.2.4.4.1 Russia Contrast Media Market by Product Type
7.2.4.4.2 Russia Contrast Media Market by Application
7.2.4.4.3 Russia Contrast Media Market by Modality
7.2.4.5 Spain Contrast Media Market
7.2.4.5.1 Spain Contrast Media Market by Product Type
7.2.4.5.2 Spain Contrast Media Market by Application
7.2.4.5.3 Spain Contrast Media Market by Modality
7.2.4.6 Italy Contrast Media Market
7.2.4.6.1 Italy Contrast Media Market by Product Type
7.2.4.6.2 Italy Contrast Media Market by Application
7.2.4.6.3 Italy Contrast Media Market by Modality
7.2.4.7 Rest of Europe Contrast Media Market
7.2.4.7.1 Rest of Europe Contrast Media Market by Product Type
7.2.4.7.2 Rest of Europe Contrast Media Market by Application
7.2.4.7.3 Rest of Europe Contrast Media Market by Modality
7.3 Asia Pacific Contrast Media Market
7.3.1 Asia Pacific Contrast Media Market by Product Type
7.3.1.1 Asia Pacific Iodinated Market by Country
7.3.1.2 Asia Pacific Barium-based Market by Country
7.3.1.3 Asia Pacific Gadolinium-based Market by Country
7.3.1.4 Asia Pacific Microbubble Market by Country
7.3.2 Asia Pacific Contrast Media Market by Application
7.3.2.1 Asia Pacific Neurological disorders Market by Country
7.3.2.2 Asia Pacific Cancer Market by Country
7.3.2.3 Asia Pacific Cardiovascular disorders Market by Country
7.3.2.4 Asia Pacific Gastrointestinal disorders Market by Country
7.3.2.5 Asia Pacific Nephrological disorders Market by Country
7.3.2.6 Asia Pacific Musculoskeletal disorders Market by Country
7.3.2.7 Asia Pacific Other Applications Market by Country
7.3.3 Asia Pacific Contrast Media Market by Modality
7.3.3.1 Asia Pacific X-ray/CT Market by Country
7.3.3.2 Asia Pacific MRI Market by Country
7.3.3.3 Asia Pacific Ultrasound Market by Country
7.3.4 Asia Pacific Contrast Media Market by Country
7.3.4.1 China Contrast Media Market
7.3.4.1.1 China Contrast Media Market by Product Type
7.3.4.1.2 China Contrast Media Market by Application
7.3.4.1.3 China Contrast Media Market by Modality
7.3.4.2 Japan Contrast Media Market
7.3.4.2.1 Japan Contrast Media Market by Product Type
7.3.4.2.2 Japan Contrast Media Market by Application
7.3.4.2.3 Japan Contrast Media Market by Modality
7.3.4.3 India Contrast Media Market
7.3.4.3.1 India Contrast Media Market by Product Type
7.3.4.3.2 India Contrast Media Market by Application
7.3.4.3.3 India Contrast Media Market by Modality
7.3.4.4 South Korea Contrast Media Market
7.3.4.4.1 South Korea Contrast Media Market by Product Type
7.3.4.4.2 South Korea Contrast Media Market by Application
7.3.4.4.3 South Korea Contrast Media Market by Modality
7.3.4.5 Singapore Contrast Media Market
7.3.4.5.1 Singapore Contrast Media Market by Product Type
7.3.4.5.2 Singapore Contrast Media Market by Application
7.3.4.5.3 Singapore Contrast Media Market by Modality
7.3.4.6 Malaysia Contrast Media Market
7.3.4.6.1 Malaysia Contrast Media Market by Product Type
7.3.4.6.2 Malaysia Contrast Media Market by Application
7.3.4.6.3 Malaysia Contrast Media Market by Modality
7.3.4.7 Rest of Asia Pacific Contrast Media Market
7.3.4.7.1 Rest of Asia Pacific Contrast Media Market by Product Type
7.3.4.7.2 Rest of Asia Pacific Contrast Media Market by Application
7.3.4.7.3 Rest of Asia Pacific Contrast Media Market by Modality
7.4 LAMEA Contrast Media Market
7.4.1 LAMEA Contrast Media Market by Product Type
7.4.1.1 LAMEA Iodinated Market by Country
7.4.1.2 LAMEA Barium-based Market by Country
7.4.1.3 LAMEA Gadolinium-based Market by Country
7.4.1.4 LAMEA Microbubble Market by Country
7.4.2 LAMEA Contrast Media Market by Application
7.4.2.1 LAMEA Neurological disorders Market by Country
7.4.2.2 LAMEA Cancer Market by Country
7.4.2.3 LAMEA Cardiovascular disorders Market by Country
7.4.2.4 LAMEA Gastrointestinal disorders Market by Country
7.4.2.5 LAMEA Nephrological disorders Market by Country
7.4.2.6 LAMEA Musculoskeletal disorders Market by Country
7.4.2.7 LAMEA Other Applications Market by Country
7.4.3 LAMEA Contrast Media Market by Modality
7.4.3.1 LAMEA X-ray/CT Market by Country
7.4.3.2 LAMEA MRI Market by Country
7.4.3.3 LAMEA Ultrasound Market by Country
7.4.4 LAMEA Contrast Media Market by Country
7.4.4.1 Brazil Contrast Media Market
7.4.4.1.1 Brazil Contrast Media Market by Product Type
7.4.4.1.2 Brazil Contrast Media Market by Application
7.4.4.1.3 Brazil Contrast Media Market by Modality
7.4.4.2 Argentina Contrast Media Market
7.4.4.2.1 Argentina Contrast Media Market by Product Type
7.4.4.2.2 Argentina Contrast Media Market by Application
7.4.4.2.3 Argentina Contrast Media Market by Modality
7.4.4.3 UAE Contrast Media Market
7.4.4.3.1 UAE Contrast Media Market by Product Type
7.4.4.3.2 UAE Contrast Media Market by Application
7.4.4.3.3 UAE Contrast Media Market by Modality
7.4.4.4 Saudi Arabia Contrast Media Market
7.4.4.4.1 Saudi Arabia Contrast Media Market by Product Type
7.4.4.4.2 Saudi Arabia Contrast Media Market by Application
7.4.4.4.3 Saudi Arabia Contrast Media Market by Modality
7.4.4.5 South Africa Contrast Media Market
7.4.4.5.1 South Africa Contrast Media Market by Product Type
7.4.4.5.2 South Africa Contrast Media Market by Application
7.4.4.5.3 South Africa Contrast Media Market by Modality
7.4.4.6 Nigeria Contrast Media Market
7.4.4.6.1 Nigeria Contrast Media Market by Product Type
7.4.4.6.2 Nigeria Contrast Media Market by Application
7.4.4.6.3 Nigeria Contrast Media Market by Modality
7.4.4.7 Rest of LAMEA Contrast Media Market
7.4.4.7.1 Rest of LAMEA Contrast Media Market by Product Type
7.4.4.7.2 Rest of LAMEA Contrast Media Market by Application
7.4.4.7.3 Rest of LAMEA Contrast Media Market by Modality

Chapter 8. Company Profiles
8.1 Bayer AG
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.1.5.2 Approvals:
8.2 General Electric (GE) Co. (GE Healthcare)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.6 SWOT Analysis
8.3 The Guerbet Group
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.3.5.3 Product Launches and Product Expansions:
8.4 Lantheus Holdings, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.5 Bracco S.p.A.
8.5.1 Company Overview
8.5.2 Regional Analysis
8.5.3 Recent strategies and developments:
8.5.3.1 Product Launches and Product Expansions:
8.5.3.2 Acquisition and Mergers:
8.5.3.3 Approvals:
8.6 Trivitron Healthcare Pvt. Ltd.
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Partnerships, Collaborations, and Agreements:
8.7 Nano Therapeutics Pvt. Ltd.
8.7.1 Company Overview
8.8 Magnus Health, LLC (Veracross LLC)
8.8.1 Company Overview
8.9 Imax Diagnostic Imaging Limited
8.9.1 Company Overview
8.1 Daiichi Sankyo Company, Limited
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expense
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
Note: Product cover images may vary from those shown
3 of 3
  • Bayer AG
  • General Electric (GE) Co. (GE Healthcare)
  • The Guerbet Group
  • Lantheus Holdings, Inc.
  • Bracco S.p.A.
  • Trivitron Healthcare Pvt. Ltd.
  • Nano Therapeutics Pvt. Ltd.
  • Magnus Health, LLC (Veracross LLC)
  • Imax Diagnostic Imaging Limited
  • Daiichi Sankyo Company, Limited
Note: Product cover images may vary from those shown
Adroll
adroll